MVK inhibitors belong to a specific chemical class that exerts their action by targeting an enzyme called "mevalonate kinase" (MVK). This enzyme plays a crucial role in the mevalonate pathway, a metabolic pathway responsible for the synthesis of isoprenoids and cholesterol in living organisms. By inhibiting MVK, these compounds interfere with the normal progression of the mevalonate pathway, disrupting the production of essential molecules vital for various cellular processes. Isoprenoids are vital components in the prenylation of proteins, which influences their localization and function within cells.
Additionally, cholesterol is essential for the maintenance of cell membranes and serves as a precursor to various signaling molecules. MVK inhibitors, through their targeted action on this specific enzyme, hold promise for potential applications in a wide range of research fields, due to their ability to modulate critical cellular processes dependent on isoprenoids and cholesterol. Understanding the mechanisms and properties of these inhibitors can provide valuable insights into cellular biology and potential avenues for further investigation and discovery in the scientific community.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $28.00 $88.00 $332.00 | 12 | |
A statin agent in research, Lovastatin, has dual actions of lowering cholesterol levels and inhibiting MVK in the mevalonate pathway. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $30.00 $87.00 $132.00 $434.00 | 13 | |
Similar to Lovastatin, Simvastatin is a statin commonly prescribed for hyperlipidemia. It also affects the mevalonate pathway by inhibiting MVK. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Among the most commonly prescribed statins, Atorvastatin not only reduces cholesterol but also inhibits MVK activity. | ||||||
Pravastatin | 81093-37-0 | sc-222188 | 50 mg | $400.00 | 1 | |
Often prescribed for its cholesterol-lowering effects, Pravastatin has been shown to have some inhibitory activity on MVK in laboratory studies. | ||||||
Rosuvastatin | 287714-41-4 | sc-481834 | 10 mg | $142.00 | 8 | |
A potent statin used to lower LDL cholesterol, Rosuvastatin can also affect the mevalonate pathway by inhibiting MVK. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
Another bisphosphonate like Alendronate, Zoledronic acid, has been studied for its potential to inhibit MVK activity. | ||||||